AHM-landing-image.png

IQVIA Insights Leverage CMS Data for Strategy Development

Are you leveraging commercial compliance data to inform critical business decisions about your promotional programming? To improve your educational reach and cultivate deeper engagement with healthcare professionals (HCPs), data that is publicly available from The Centers for Medicare & Medicaid Services (CMS) Open Payment platform can be leveraged as a valuable source of information. IQVIA has the resources and proprietary data to provide key insights and strategic actions to improve promotional programs and engagements.

Download this new IQVIA Commercial Compliance white paper and discover:

  • Important insights that can inform a Life Sciences company’s speaker program activity in many ways
  • Key benchmarks to look for when evaluating promotional activities and spending against those of competing brands or products
  • How IQVIA’s proprietary and unparalleled data and analytics services, when combined with Open Payments data, provides the basis for commercial activity guidance for Life Sciences companies
  • And more
AHM-landing-image.png

Trends and Opportunities for the Life Sciences Industry

AHM’s unique market positioning enables us to not only collect Health Care Professional (HCP) engagement data but it also allows us to analyze and draw insights to evaluate regulatory, compliance and other trends that show how the industry is changing—and where the next opportunities for growth lie.

Download this new white paper and discover:

  • Important industry benchmarks that can be used to target behaviors and enhance engagement with HCPs
  • New  cost saving methods to utilize when planning HCP engagements
  • How to leverage Key Opinion Leaders (KOLs) when planning programs
  • How to better harness HCP engagement data, to deliver value to your HCP meetings and engagements
  • And more

KOI (2).pngA Not-to-Miss White Paper from AHM

Key Opinion Leaders (KOLs), also known as thought leaders, are physicians; healthcare professionals whose expertise, reputation and professional following is used by the Life Sciences industry to provide knowledgeable research and support on therapies, both old and new throughout the drug development process.

Download this white paper and learn about:

  • Key approaches to engage KOLs
  • Regulations affecting KOLs globally
  • How to select a KOL
  • And more
AHM-landing-image.png

A 5-Year Industry Trend Analysis

AHM continually monitors key trends and statistics in the Life Sciences Industry. This 5-year analysis reveals that live programming and HCP attendance are robust, despite fewer drug approvals and Open Payments reporting.  Download this white paper and discover:

 

  • A better understanding of trends associated with the management and execution of promotional speaker programs.
  • The average attendance per program, cost per program, and spend by attendee type over the past 5 years
  • Important industry benchmarks
  • And more

A New White Paper by AHM

Life Sciences is among the more highly regulated industries in business today, with pharmaceutical and related firms subject to scrutiny from federal and state-level regulatory agencies regarding their interactions with healthcare professionals (HCPs). Entering into a Corporate Integrity Agreement (CIA) can be a challenge, but it is by no means an uncommon one. This document is intended both for firms operating under a CIA, as well as those that want to enhance efforts to steer clear of compliance issues and hopefully avoid the need to enter into a CIA.

CIA-whitepaper-image.jpg

Download this new AHM White Paper and learn more about:
  • Operational Risk Areas that can Trigger a CIA
  • Key Categories of CIA Compliance
  • Elements of Compliance-Centric Engagements
  • Factors Necessary for Facilitating Compliance-Centric Speaker Programming
  • The Final Frontier of Reporting
  • And more
executive-perspective.png

The culture of HCP Engagement and Speaker Programs has changed dramatically over the years with the dramatic growth of regulation and compliance. Each compliance mandate was aimed at making the relations between the industry and HCPs more transparent and each brought to bear the triad of public opinion, potentially painful penalties, and a new focus on compliance as a key corporate value.

 

In this white paper, AHM’s Peter Collins discusses how compliance impacts HCP engagements, and steps that Life Sciences companies can take to improve their speaker program efforts.

SMM-2.png

This white paper focuses on strategic meetings management programs (SMMPs) — it highlights the rationale for next generation SMM to ensure compliance as meetings expand globally and compliance requirements become universal. It also provides important insights from key stakeholders in SMMP.

Avoiding-Risk (2).pngA Not-to-Miss White Paper from AHM

For Life Sciences organizations, information related to compliance is of crucial importance. The industry is enduring close regulatory scrutiny, which is likely to continue to expand in scope. One major challenge involves implementing processes to ensure complete and accurate retention of data and compliance with relevant systems.

Download this white paper and learn about:

  • Important ways to ensure data quality
  • How to address the data challenge
  • How to implement quality results
  • And more
EEPIA-white.png

Driven by a multitude of regulatory requirements, disclosure of information relating to relationships in the healthcare field and especially “transfers of value” is now a fact of life for Life Science organizations. With the US e­ffectively taking the lead, other markets have followed or are following a path toward more information transfers, more record keeping, and more complexity, all in the name of the laudable goal of transparency.

Download this white paper and learn more about the cornerstones of meeting global transparency requirements; including the need for a robust technology portfolio linked with service solutions, transparency of data amongst the organization and affiliates, and more.

Meal-Caps-white.png

To someone outside of the Life Science industry, the term meal cap probably sounds innocuous and perhaps a little puzzling. Meal caps are related to verb use – to “cap,” meaning to put a restriction (usually on cost or price) on “something.” In the Life Sciences industry, that most often has to do with payments subject to a range of compliance limitations, especially the wide-ranging Open Payments “Sunshine” Act law in the U.S. or similar laws elsewhere.

The purpose of this paper is to provide perspectives relative to all stakeholders involved with the specific impact of meal caps or hospitality restrictions associated with the Life Sciences manufacturers and health care professionals (HCPs).